Results: 5

For: psychosis AND CBT AND systematic review

Psychosocial interventions for negative symptoms in psychosis

pexels-photo-271897

Rachel Upthegrove reviews a new systematic review and meta-analysis of psychological and psychosocial interventions for negative symptoms in psychosis.

This is the third in a new series of Mental Elf blogs produced in partnership with the British Journal of Psychiatry.

[read the full story...]

CBTp and medication in the treatment of psychosis: summarising the best evidence

shutterstock_158430557

Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015

[read the full story...]

Service user perspectives on individual CBT for psychosis

shutterstock_140282743

I have been procrastinating about writing this blog for a while. This is, in part, caused by hesitancy about involving myself in the CBT for psychosis (CBTp) debate. Regular readers of the Mental Elf will be aware that in recent months Jauhar and colleagues presented results of a meta-analysis that called into question the effectiveness [read the full story…]

Individual CBT, with or without family CBT, could be the best first line treatment for people at high risk of schizophrenia

Colour transition

Schizophrenia is a debilitating illness that affects an estimated 25 million people worldwide. People with the condition can experience a huge amount of disability (both social, physical and psychological), but we know that early intervention can help reduce the duration of the illness and prevent further episodes of relapse. People with schizophrenia usually experience a [read the full story…]

The most effective treatments for preventing relapse in first episode psychosis: a new systematic review and meta-analysis

shutterstock_56881219

Patients with first episode psychosis often relapse after initial remission, so it is perhaps surprising that treatment guidelines for the condition are generally based on poor quality evidence. Antipsychotic drugs are frequently discontinued, but clinicians don’t have ready access to information that shows how to determine which patients can be successfully tapered off of antipsychotic [read the full story…]